Brand Engagement Network Inc. (BNAI) and INTERVENT International, LLC Enter Material Agreement for Health AI Subsidiary
Key Highlights
- Brand Engagement Network Inc. (BNAI) files Form 8-K announcing the signing of a Founding Shareholders Agreement with INTERVENT International, LLC.
- The agreement pertains to the governance and equity structure of Health AI, a new joint venture.
- The arrangement covers the issuance of common and preferred stock, reserved shares for future issuance, and sets clear terms for capital raising, valuation, and exit strategies.
- Both companies will have equal control of Health AI at inception, each holding 50% of the issued and outstanding shares.
- Material terms are outlined for future funding, board approvals, and mechanisms for resolving disputes between the founding shareholders.
Details of the Founding Shareholders Agreement
Equity Structure and Share Issuance
- Health AI is authorized to issue:
- Up to 100,000,000 shares of Class A Common Stock at a par value of \$0.0001 per share.
- Of this, BEN (Brand Engagement Network Inc.) will receive 32,500,000 shares (representing 50% of the issued and outstanding shares at inception).
- INTERVENT International, LLC will also receive 32,500,000 shares (representing the remaining 50%).
- 30,000,000 shares are to be reserved for future issuance, subject to the approval of Health AI’s Board of Directors.
- Preferred Stock:
- Health AI is also authorized to issue 10,000,000 shares of Class B Preferred Stock at a par value of \$1.00 per share.
- BEN and INTERVENT will each be allocated 5,000,000 shares of Class B Preferred Stock.
Future Capital Raising and Valuation
- Initial Capital Raise:
- BNAI will identify investors to raise \$1,000,000 in exchange for 4,000,000 of the reserved shares, at a minimum valuation for Health AI of \$25,000,000 (as established by the Board of Directors).
Exit Strategy and Dispute Resolution
- If a conflict arises between the Founding Shareholders, or after seven years from Health AI’s incorporation:
- Both parties agree to attempt to sell or buy out the other’s equity in Health AI, or sell their shares back to Health AI, allowing the remaining owner to operate the company.
- If there is a disagreement about Health AI’s fair market value, an independent valuation will be performed by a mutually agreed and qualified entity, paid for by Health AI.
- If a sale between the parties cannot be achieved, both must sell their shares to a mutually agreeable third party.
- These exit strategies are voided if Health AI raises at least \$10,000,000 in post-incorporation capital or is independently valued at \$50,000,000 or more.
Potential Impact for Shareholders
- Price Sensitive Information: The agreement establishes clear, concrete mechanisms for major corporate actions within Health AI, including capital increases, reserved shares for strategic purposes, and triggers for buy/sell arrangements between the founding shareholders.
- Future Dilution: There is a significant portion (30,000,000 shares) reserved for potential future issuance, which could result in dilution for existing shareholders depending on how these shares are allocated.
- Capital Injection and Valuation: The agreement sets a floor valuation of \$25 million for Health AI for the initial outside investment, and establishes higher triggers (\$10 million in capital raised or a \$50 million valuation) that would void the exit mechanisms. These thresholds indicate an ambitious growth plan and could have a material impact on BNAI’s valuation and market perception if met.
- Governance and Control: Both founding shareholders begin with equal control, but future capital events and board actions could shift the balance. Investors should monitor future issuances and board decisions closely.
- Exit Provisions: The mechanism for resolving deadlocks or conflicts—including possible forced sales—provides clarity around ownership continuity but also introduces the possibility for significant changes in shareholding structure.
Other Notable Regulatory and Exchange Information
- BNAI Common Stock (par value \$0.0001 per share) and Redeemable Warrants (each whole warrant exercisable for one common share at an exercise price of \$11.50 per share) are both listed on NASDAQ under the symbols BNAI and BNAIW, respectively.
- BNAI is classified as an Emerging Growth Company under SEC rules and has not opted out of the extended transition period for complying with new or revised financial accounting standards.
- No written communications, soliciting materials, or pre-commencement tender offers are included or triggered by this 8-K filing.
Conclusion
This Founding Shareholders Agreement between Brand Engagement Network Inc. and INTERVENT International, LLC is a significant step in the formalization and capitalization of Health AI. It provides a detailed framework for equity structure, future fundraising, governance, and exit strategies. The clarity and ambition of these arrangements may be price sensitive, especially as the company pursues milestones such as a \$10 million capital raise or a \$50 million independent valuation. Shareholders should closely monitor subsequent filings for updates regarding capital raises, share issuances, and any developments around the reserved shares and board actions.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with their financial advisors before making investment decisions. The information herein is based on publicly available filings and may be subject to change.
